UPB
UPB
NASDAQ · Biotechnology

Upstream Bio Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$6.25
+0.10 (+1.63%)
As of Jun 21, 10:08 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +294.9% upside
Low Target $18.50
Average Target $24.68
High Target $35.72
Current Price $6.25
Current
$6.25
Target
$24.68
$18.50 $24.68 avg $35.72
Scenario Analysis
Bear Case
$18.50
196.0%
Low target
Base Case
$24.68
+294.9%
Avg target
Bull Case
$35.72
+471.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$33.68
-81.4% from high
52-Week Low
$5.85
+6.8% from low
Target vs 52W High
$24.68
-26.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%